leukemia – Josha Journal

18. August 2019 | DOI: 10.17160/josha.6.8.591

Unravelling the syndrome of age associated diseases 2: Targeting autoimmunity with anti-CD20 antibodies to reduce age-associated diseases

R

Roland Mertelsmann, Katja Zirlik

Albert-Ludwigs Universität

The antibody Rituximab that was originally used to treat non-Hodgkin's lymphoma or chronic lymphocytic leukemia was found to be effective for all autoimmune diseases studied so far. This raises the…

1,593

2,673

International Conference PHILOSOPHY AND CANCER (IHPST Paris) April 28,2016

T

Thomas Pradeu, Lucie Laplane

International Conference PHILOSOPHY AND CANCER APRIL 28TH, 2016 Institute for the History and Philosophy of Science and Technology (IHPST) 13 rue du Four 75006 Paris Second Floor, conference room 9:30…

1,715

3,918

The Scientific, Social and Ethical Aspects of Prolonging Human Life

C

Christoph Borner

Professor Borner is a leading scientist in the field of apoptosis research. His career and activities include the following stations: 2014-present Director of the International Master Program in Medical and…

1,661

4,044